Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Int J Vitam Nutr Res. 2008 May;78(3):105–111. doi: 10.1024/0300-9831.78.3.105

Table IV.

Dietary carotenoid intake for women with and without osteoporosis1

Carotenoid
(mg/d)		 Osteoporotic group
(n = 25)		 Control group
(n = 24)
Lutein/zeaxanthin 1.27 ± 2.09 0.82 ± 1.14
β-Cryptoxanthin 0.16 ± 0.19 0.09 ± 0.152
Lycopene 0.59 ± 1.08 1.57 ± 3.21
α-Carotene 0.19 ± 0.33 0.70 ± 2.52
β-Carotene 1.02 ± 1.38 2.09 ± 5.16
1

Values are means ± SD.

2

In the multiple linear regression model, after adjusting for age, BMI, supplement use, fruit and vegetable consumption, and milk intake, β-cryptoxanthin intake is significantly higher in the osteoporosis group as compared with the control group (p = 0.0046) and relates to a difference in fruit intake (p < 0.0001) in the same model.